NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Shire plc 

725 Chesterbrook Boulevard

Wayne  Pennsylvania  19087-5637  U.S.A.
Phone: 484-595-8800 Fax: 484-595-8200


SEARCH JOBS










 Company News
Shire plc Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 11/16/2009 11:26:25 AM    More...
Shire plc Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules 11/11/2009 8:30:52 AM    More...
Shire plc: Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 11/9/2009 8:33:54 AM    More...
Shire plc Extends Agreement with Medidata Solutions, Inc. for Trial Planning Products 11/4/2009 9:24:14 AM    More...
FDA Grants Priority Review for Shire plc's (JOBS) Velaglucerase Alfa for Type 1 Gaucher Disease; PDUFA Date is February 28, 2010 11/4/2009 6:29:56 AM    More...
New Shire plc Board Member 11/2/2009 8:54:43 AM    More...
Shire plc Reports Tolerability and Clinical Effects Results of Daytrana(R) 11/2/2009 8:38:00 AM    More...
Shire plc to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 10/30/2009 9:05:12 AM    More...
Shire plc Continues to Deliver Excellent Growth From Core Products 10/30/2009 8:23:22 AM    More...
Amicus Therapeutics, Inc. (FOLD) (JOBS) Reacquires Global Development and Commercialization Rights to Amigal(TM), Plicera(TM) and AT2220 Through a Mutual Termination Agreement with Shire plc (JOBS); Company to Cut 20 Percent Jobs; Announces Third Quarter 2009 Financial Results 10/30/2009 8:14:30 AM    More...
1234567